| P50 | author | Mirela Delibegovic | Q84021168 |
| | Nimesh Mody | Q57321366 |
| P2093 | author name string | George D Mcilroy | |
| | Patrick N Stoney | |
| | Peter J McCaffery | |
| | Kirsty D Shearer | |
| | Carl Owen | |
| P2860 | cites work | N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid | Q72657599 |
| | Dietary vitamin A supplementation in rats: suppression of leptin and induction of UCP1 mRNA | Q77388330 |
| | Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients | Q93521069 |
| | Chronic vitamin A intoxication in adults. Hepatic, neurologic and dermatologic complications | Q93695432 |
| | Retinoic acid negatively regulates neuropeptide Y expression in human neuroblastoma cells | Q40873665 |
| | Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide | Q41049278 |
| | In vitro and in vivo induction of brown adipocyte uncoupling protein (thermogenin) by retinoic acid | Q41181250 |
| | N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma | Q41289818 |
| | Intracerebroventricular administration of neuropeptide Y induces hepatic insulin resistance via sympathetic innervation | Q41777277 |
| | Effect of the synthetic retinoid fenretinide on dark adaptation and the ocular surface | Q42503866 |
| | Inhibition of adipose conversion in 3T3-L2 cells by retinoic acid | Q42829102 |
| | 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors | Q46690362 |
| | Differential effects of retinoic acid on uncoupling protein-1 and leptin gene expression | Q47864671 |
| | Effects of STZ-Induced Diabetes and Fasting on Insulin Receptor mRNA Expression and Insulin Receptor Gene Transcription in Rat Liver | Q51603391 |
| | Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression. | Q54123342 |
| | A Novel Regulatory Pathway of Brown Fat Thermogenesis | Q60636934 |
| | In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences | Q67546270 |
| | Long-term tolerability of fenretinide (4-HPR) in breast cancer patients | Q67904678 |
| | Preadipocytes possess cellular retinoid binding proteins and their differentiation is inhibited by retinoids | Q72151835 |
| | Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes | Q24309211 |
| | Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation | Q24317692 |
| | A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 |
| | Overview of retinoid metabolism and function | Q28026612 |
| | Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations | Q28264846 |
| | Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein | Q28509835 |
| | Genetic evidence that retinaldehyde dehydrogenase Raldh1 (Aldh1a1) functions downstream of alcohol dehydrogenase Adh1 in metabolism of retinol to retinoic acid | Q28587546 |
| | A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARalpha to target promoters | Q28594426 |
| | Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogs | Q33263984 |
| | Cellular retinol-binding protein type I (CRBP-I) regulates adipogenesis | Q33963887 |
| | Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance | Q34150792 |
| | Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis | Q34184654 |
| | Classical and novel retinoids: their targets in cancer therapy | Q34605217 |
| | Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle | Q34790967 |
| | Concerted action of aldehyde dehydrogenases influences depot-specific fat formation. | Q34856359 |
| | Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. | Q35603208 |
| | Retinoic acid upregulates preadipocyte genes to block adipogenesis and suppress diet-induced obesity | Q35902881 |
| | Clinical trials with retinoids for breast cancer chemoprevention | Q36443030 |
| | Retinaldehyde represses adipogenesis and diet-induced obesity. | Q36444754 |
| | Mechanisms of fenretinide-induced apoptosis | Q36540587 |
| | Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer. | Q37008398 |
| | Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis | Q37474455 |
| | Retinoic acid and vitamin D(3) powerfully inhibit in vitro leptin secretion by human adipose tissue | Q38298323 |
| | Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. | Q38311559 |
| | Distribution of fenretinide in the mammary gland of breast cancer patients | Q38534184 |
| | N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat | Q38537718 |
| | Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARgamma | Q40018541 |
| | Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription | Q40021186 |
| | Insulin Receptors and Insulin Resistance | Q40150685 |
| | Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1. | Q40511114 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 825-836 | |
| P577 | publication date | 2012-11-27 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Fenretinide treatment prevents diet-induced obesity in association with major alterations in retinoid homeostatic gene expression in adipose, liver, and hypothalamus | |
| P478 | volume | 62 | |